Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISRCTN13866189Phase 3Completed
Phase 3, randomised, open-label trial of metformin and human insulin in diabetes mellitus (DM), gestational diabetes mellitus (GDM) and type 2 diabetes mellitus (T2DM) (2 arms), sponsored by The University of Manchester. Started Oct 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ISRCTN13866189.